Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;83(2):237-279.
doi: 10.1016/j.jinf.2021.05.017. Epub 2021 May 25.

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan

Shohei Yamamoto  1 , Akihito Tanaka  2 , Yusuke Oshiro  2 , Masamichi Ishii  3 , Hironori Ishiwari  3 , Maki Konishi  1 , Kouki Matsuda  4 , Mitsuru Ozeki  2 , Kengo Miyo  3 , Kenji Maeda  4 , Tetsuya Mizoue  5 , Wataru Sugiura  6 , Hiroaki Mitsuya  7 , Haruhito Sugiyama  8 , Norio Ohmagari  9
Affiliations

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan

Shohei Yamamoto et al. J Infect. 2021 Aug.
No abstract available

Keywords: COVID-19; Health personnel; Immunoassay; Japan; SARS-CoV-2; Seropidemiologic studies.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Antibody test reagents were provided by Abbott and Roche Diagnostic.

Figures

Fig. 1
Fig. 1
Change in the number of patients diagnosed with COVID-19 in Japan.
See this image and copyright information in PMC

References

    1. Gómez-Ochoa S.A., Franco O.H., Rojas L.Z., Raguindin P.F., Roa-Díaz Z.M., Wyssmann B.M. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–175. - PMC - PubMed
    1. Galanis P., Vraka I., Fragkou D., Bilali A., Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect. 2021;108:120–134. - PMC - PubMed
    1. Jeremias A., Nguyen J., Levine J., Pollack S., Engellenner W., Thakore A. Prevalence of SARS-CoV-2 infection among health care workers in a tertiary community hospital. JAMA Intern Med. 2020;180(12):1707. - PMC - PubMed
    1. Jacob J.T., Baker J.M., Fridkin S.K., Lopman B.A., Steinberg J.P., Christenson R.H. Risk factors associated with SARS-CoV-2 seropositivity among us health care personnel. JAMA Netw Open. 2021;4(3) - PMC - PubMed
    1. Sikkema R.S., Pas S.D., Nieuwenhuijse D.F., O'Toole Á., Verweij J., Van Der Linden A. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study. Lancet Infect Dis. 2020;20(11):1273–1280. - PMC - PubMed

Publication types

Substances